Status:
COMPLETED
Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer
Lead Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University
Conditions:
Metastatic Pancreatic Cancer
Eligibility:
All Genders
18-75 years
Phase:
PHASE1
Brief Summary
Eligible candidates will be adults with metastatic pancreatic cancer (confirmed diagnosis with pathology reports and measurable computed tomography (CT) or magnetic resonance imaging (MRI)). Participa...
Eligibility Criteria
Inclusion
- Metastatic pancreatic cancer
- Glucose 6 phosphate dehydrogenase status normal
- ECOG performance status 0-2
- Normal creatinine and transaminase
- Women of child-bearing potential confirm negative pregnancy test
Exclusion
- Concurrent chemotherapy or radiotherapy
- Significant co-morbid disorders
- Significant psychiatric symptoms
- Prior treatment with gemcitabine
- Concurrent chronic use of immunosuppressive agents (methotrexate, cyclosporine,corticosteroids)
- Regular use of nonsteroidal anti-inflammatory agents
- Smoking more than 1 pack per day
- Excessive alcohol or drug use
- Enrollment in other experimental therapy
- Active infection
- Patients experiencing ongoing response to recent treatments
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00954525
Start Date
July 1 2009
End Date
December 1 2011
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jefferson-Myrna Brind Center of Integrative Medicine
Philadelphia, Pennsylvania, United States, 19107